首页> 外国专利> compound, pharmaceutical composition, and methods for antagonizing cgrp receptor activity in a mammal to treat, control, ameliorate or reduce the risk of headache, migraine or headache, and treating or preventing migraine headaches. , headaches, and headaches

compound, pharmaceutical composition, and methods for antagonizing cgrp receptor activity in a mammal to treat, control, ameliorate or reduce the risk of headache, migraine or headache, and treating or preventing migraine headaches. , headaches, and headaches

机译:用于拮抗哺乳动物中cgrp受体活性以治疗,控制,减轻或降低头痛,偏头痛或头痛的风险,以及治疗或预防偏头痛的化合物,化合物,药物组合物和方法。 ,头痛和头痛

摘要

COMPOSITION, PHARMACEUTICAL COMPOSITION, AND METHODS FOR ANTIGONISM OF CGRP RECEIVER ACTIVITY IN A MAMMER, TO TREAT, CONTROL, IMPROVE OR REDUCE THE RISK OF HEADACHE, THRESHEME OR PREFACTURE OF HEADACHES , HEADACHES, AND HEADACHES. The invention relates to compounds of Formula (I) and Formula (II): (wherein the variables R 1, R 4, A, B, D, W, X, Y and Z are as defined herein) as CGRP receptor antagonists and useful in treating or preventing diseases in which CGRP is involved, such as headache, migraine, and crowded headache. The present invention is also directed to pharmaceutical compositions comprising these compounds and to the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
机译:哺乳动物CGRP受体活性的成分,药物成分和抗药性,以治疗,控制,改善或降低头疼,头疼和头疼的头痛,喉咙痛或早泄的风险。本发明涉及式(I)和式(II)的化合物:(其中变量R 1,R 4,A,B,D,W,X,Y和Z如本文所定义)作为CGRP受体拮抗剂并且有用用于治疗或预防与CGRP有关的疾病,例如头痛,偏头痛和拥挤头痛。本发明还涉及包含这些化合物的药物组合物,以及这些化合物和组合物在预防或治疗涉及CGRP的此类疾病中的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号